Analysis of pneumonia severity based on CURB-65 scoring system and its implications for empirical antibiotics: A Cross Sectional Study at Regional Hospital Denpasar
##plugins.themes.bootstrap3.article.main##
Abstract
The largest case of pneumonia found in the community is community-acquired pneumonia, with the main problem of high severity in elderly patients. The severity of pneumonia can be measured, one of which is through the CURB-65 method, which is widely used in various health services to determine the antibiotics used. This study was aimed to see the relationship between the severity of pneumonia and empirical antibiotic therapy at the Denpasar City Hospital. The research method used is descriptive analytic with a cross-sectional approach with a study population including all patients diagnosed with community-acquired pneumonia and hospitalized at the Regional Hospital Denpasar in 2022-2023 who meet the inclusion and exclusion criteria. Bivariate analysis was used to see the relationship between the severity of pneumonia and empirical antibiotic therapy. The number of samples that met the inclusion and exclusion criteria was 152 samples consisting of 64 patients receiving antibiotic monotherapy and 88 patients receiving antibiotic polytherapy. The severity of pneumonia through the CURB-65 score is dominated by mild severity (71.7%). Through the Fisher exact test, a p-value < 0.05 was obtained, which means that there is a relationship between the severity of pneumonia and empirical antibiotic therapy at the Regional Hospital Denpasar. The results of this study are in line with the guidelines for managing community acquired pneumonia in Indonesia.
Downloads
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2026 Raja Baskara Adi Pradana, Pande Ayu Naya Kasih Permatananda, Desak Putu Citra Udiyani, Pande Ayu Berliana Dekananda Pandit, Sri Agung Aryastuti

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Rodríguez A, Mendia A, Sirvent JM, et al. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med. 2007;35(6):1493-1499. doi:10.1097/01.CCM.0000266755.75844.05
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):E45-E67. doi:10.1164/rccm.201908-1581ST
Kementerian Kesehatan RI. Laporan Riskesdas 2018 Nasional.; 2018.
Permatananda PANK, Widhidewi NW. Penggunaan Antibiotik Empiris Pada Pasien Pneumonia Empirical Use of Antibiotics in Pneumonia Patients Penggunaan Antibiotik Empiris Pada Pasien Pneumonia. Medika Respati: Jurnal Ilmiah Kesehatan. 2021;16(4):249-256. doi:10.35842/mr.v16i4.468
Rosdiana D, Merlinda Veronica R, Harahap S, et al. Frekuensi Karier Streptococcus pneumoniae pada Populasi Dewasa Suku Akit Provinsi Riau. Jurnal Ilmu Kedokteran. 2024;18. doi:10.26891/JIK.v18i2.2024
Ketut Surya Negara. Analysis The Implementation Policy of Rational Use of Antibiotics to Prevent Antibiotic Resistance In Sanglah Hospital Denpasar: Case Study of Methicillin Resistant Staphylococcus Aureus Infections. Jurnal Administrasi Rumah Sakit Indonesia. 2014;1(1). doi:10.7454/arsi.v1i1.2169
Farida Y, Putri VW, Hanafi M, Herdianti NS. Profil Pasien dan Penggunaan Antibiotik pada Kasus Community-Acquired Pneumonia Rawat Inap di Rumah Sakit Akademik wilayah Sukoharjo. JPSCR: Journal of Pharmaceutical Science and Clinical Research. 2020;5(2):151. doi:10.20961/jpscr.v5i2.39763
Zaki HA, Hamdi Alkahlout B, Shaban E, et al. The Battle of the Pneumonia Predictors: A Comprehensive Meta-Analysis Comparing the Pneumonia Severity Index (PSI) and the CURB-65 Score in Predicting Mortality and the Need for ICU Support. Cureus. 2023;15(7):e42672. doi:10.7759/cureus.42672
Aulia Natasya F, Natasya FA, Dokter P, Kedokteran F. Tata Laksana Pneumonia. Jurnal Medika Hutama. Published online 2022. http://jurnalmedikahutama.com
Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. The Lancet. 2015;386:1097-1108. doi:10.1016/S0140-6736(15)60733-4
Halim S. Validation of CURB-65 Scoring System in Indonesian Patients with HAP. www.cdc.gov/ncidod/hop/nnis/members/
Aydin M, Şaylan B, Ekiz İşcanlı İG. Factors associated with mortality in younger and older (≥75 years) hospitalized patients with community-acquired pneumonia. Ann Saudi Med. 2022;42(1):45-51. doi:10.5144/0256-4947.2022.45
Mecy Alvinda Sari, Raveinal, Noverial. Derajat Keparahan Pneumonia Komunitas pada Geriatri Berdasarkan Skor CURB-65 di Bangsal Penyakit Dalam RS. Dr. M. Djamil Padang Tahun 2016. Jurnal Kesehatan Andaas. 2018;7(1):102-107.
Abdul Salam Malik, Muhammad Iqbal Khan. Profiles of community acquired pneumonia cases admitted to a Tertiary Care Hospital. Pak J Med Sci. 2012;28(1):75-78.
Gutiérrez F, Masiá M, Mirete C, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. Journal of Infection. 2006;53(3):166-174. doi:10.1016/j.jinf.2005.11.006
Armitage K, Woodhead M. New guidelines for the management of adult community-acquired pneumonia. Curr Opin Infect Dis. 2007;20:170-176. www.brit-thoracic.org.uk/guidelines
Widasari N. Pola Derajat Keparahan Pneumonia Dan Terapi Antibiotik Empirik Pada Pasien Community-Acquired Pneumonia (CAP) Yang Dirawat Di RSUP Dr. Kariadi Semarang.; 2014.
Pradipta IS, Febrina E, Ridwan MH, Ratnawati R. Identifikasi Pola Penggunaan Antibiotik sebagai Upaya Pengendalian Resistensi Antibiotik. Jurnal Farmasi Klinik Indonesia. 2012;1(1):16-24. http://www.whocc.no/atc_ddd_in-
Bellmann R, Kuchling G, Dehghanyar P, et al. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br J Clin Pharmacol. 2004;57(5):563-568. doi:10.1111/j.1365-2125.2004.02059.x
Rike Syahniar, Muhammad Afif Akbar, Dayu Swasti Kharisma, Audia Nizhma Nabila. Comparison Between Monotherapy and Combination Therapy among Inpatients with Community-Acquired Pneumonia. Scientific Journal of Pharmacy. 2021;17(1):56-63.
Permatananda PA, Pandit PA. The outcome difference of monotherapy versus combination therapy among patients with pneumonia: a systematic review. Minerva Med.Edizioni Minerva Medica. 2025;116(2):135-140. doi:10.23736/S0026-4806.24.09446-1
Rahmel T, Asmussen S, Karlik J, Steinmann J, Adamzik M, Peters J. Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS. BMC Anesthesiol. 2017;17(1). doi:10.1186/s12871-017-0376-5
Metersky ML, Ma A, Houck PM, Bratzler DW. Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones. Chest. 2007;131(2):466-473. doi:10.1378/chest.06-1426
Githarani AAV, Permatananda PANK, Pandit PABD, Evayanthi LG. Differences in Length of Hospitalization in Pneumonia patients Receiving Monotherapy and Polytherapy Empirical Antibiotic: Study at Tertiary Referral Hospital, Bali. Res J Pharm Technol. 2025;18(5):2121-2126. doi:10.52711/0974-360X.2025.00304
Raja Baskara Adi Pradana